Navigation Links
Haemacure Reports First Quarter 2009 Results and Hires Advisor for the Sale or Merger of the Company
Date:3/12/2009

HAE:TSX

MONTREAL, March 12 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : HAE) released today the results of its first quarter ended January 31, 2009.

Results

Revenues amounted to $19,226, as compared to $24,674 for the same quarter last year. Revenues were exclusively derived from the sale of legacy fibrin sealant application devices. Operating expenses amounted to $2.7 million, up from $1.2 million for the same quarter last year. The increase was mainly related to the purchase of supplies and materials associated with the validation of the Company's manufacturing facility, and the pivotal phase II/III clinical trials of its lead product candidate (which had been planned to start by mid-2009), as well as the hiring of personnel and legal and consulting fees. The consolidated net loss for the quarter amounted to $2.6 million, or $0.01 per share, as compared to $1.2 million, or $0.01 per share, for the same quarter last year.

Financial Position

Cash, cash equivalents and temporary investments amounted to $1.4 million as of January 31, 2009, as compared to $4.6 million as at October 31, 2008.

On February 13, 2009, Haemacure, having failed to obtain adequate financing to maintain the level of its operations, implemented major cost cutting measures intended to provide the Company with a window of approximately 90 days in which to either arrange a bridge loan, obtain new financing, or sell or merge the Company. The Company has since retained PricewaterhouseCoopers Corporate Finance, Inc. to assist with the sale or merger of the Company.

"We have taken the necessary steps to lengthen our runway in these unprecedented financial and economic times. While these measures are difficult for all involved we have had tremendous support from our directors, employees, suppliers and business partners. I am encouraged by the number of industry members that have come forw
'/>"/>

SOURCE HAEMACURE CORPORATION
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Haemacure Restructures - Seeks Financing or Sale of the Company
2. Haemacure to Present at the 11th Annual BIO CEO & Investor Conference
3. Haemacure Announces Fiscal 2008 Results
4. Haemacures Human Fibrin Sealant Demonstrates Effectiveness in Skin Graft Fixation Proof-of-Concept Study for Burn Injury
5. Haemacure Confirms Operation Qualification of Production Equipment and Pursues Milestone Payment from CSL
6. Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference
7. Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
8. Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
9. Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic
10. Haemacure to Present at the BioInternational Convention - The Global Event for Biotechnology - at the San Diego Convention Centre, California, from June 17 - 20, 2008
11. Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... TX (PRWEB) November 18, 2014 ... advice and insights, adding to the company's reputation ... Explore everything the blog has to offer at ... through all the information concerning the Affordable Care ... blog aims to inform the public about a ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... An experimental antibody drug could prove effective at lowering ... effects with cholesterol-lowering statin medications. That,s the conclusion ... Heart Association annual meeting in Chicago. The drug, ... most widely used alternative to statins, Zetia, said lead ...
(Date:11/18/2014)... Women who started smoking at a young age may ... a new study suggests. About 29 percent of ... suspected as a risk factor for severe menstrual pain, ... new study said. The researchers analyzed data from ... women,s health in Australia. About 14 percent of the ...
(Date:11/18/2014)... GA (PRWEB) November 18, 2014 ... focused on using the telehealth platform to bring ... Because of this passion, GPT created Global Partnership ... utilizing GPT’s already existing telehealth network. GPTM ... orphanages, hospitals overseas, and disaster relief organizations. ...
(Date:11/18/2014)... (PRWEB) November 18, 2014 Sometimes at ... situations with print devices like unforeseen error messages or ... don't have time to find another printer and they ... The IT department is likely tied up with other ... , That’s where Electronic Systems, Inc. (ESI) ...
Breaking Medicine News(10 mins):Health News:Medicationdiscountcard.com Building Virtual Library of Resources to Help Consumers Navigate Healthcare Landscape 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 3Health News:Study Ties Teen Smoking to Risk of Severe Menstrual Cramps 2Health News:Global Partnership for TeleHealth (GPT) is Focused on Using the telehealth Platform to Bring Quality Healthcare to Populations in Need Worldwide 2Health News:Electronic Systems, providing Managed Print Services (MPS) in Virginia & Outer Banks North Carolina 2
... Researchers at the University of Florida and Metagenics Inc. today ... combined with a low-glycemic, Mediterranean-style diet is almost twice as ... risk factors for cardiovascular disease, the leading cause of death ... medical food UltraMeal PLUS 360 is 40 percent more likely ...
... May 19 (HealthDay News) -- Summer fun can take a ... a common infection that accounts for almost $500 million in ... report. Swimmer,s ear results in 2.4 million doctor ... average of $200, according to the report from the U.S. ...
... FL (May 19, 2011)Researchers from the University of Miami (UM) ... different teaching models for children with Autism Spectrum Disorder (ASD). ... the fidelity of treatment models for preschoolers with autism. ... the journal Research in Autism Spectrum Disorders . ...
... ARBOR, Mich. A primary reason that head and neck ... chemotherapy drugs. Now, researchers at the University of Michigan Comprehensive ... Indian spice curcumin can help cells overcome that resistance. ... head and neck cancer cell lines, they were able to ...
... have been diagnosed with poor sperm quality and who are ... Researchers have found that while cell phone use appears to ... may also lead to low sperm quality and a decrease ... puzzling," says Rany Shamloul, a postdoctoral fellow in the Department ...
... Crohn,s patients in a research study at Penn ... a chronic inflammatory condition of the gastrointestinal tract ... loss. Treatments for Crohn,s disease are designed to ... rare but serious side effects, including infections and ...
Cached Medicine News:Health News:Breakthrough medical food reverses risk of heart disease and diabetes 2Health News:Breakthrough medical food reverses risk of heart disease and diabetes 3Health News:Swimmer's Ear Costs Up to $500 Million a Year in U.S. 2Health News:Validating preschool programs for children with autism 2Health News:Curcumin compound improves effectiveness of head and neck cancer treatment, U-M study finds 2Health News:Use of naltrexone reduces inflammation in Crohn's patients 2
(Date:11/18/2014)... , Nov. 17, 2014   Headquartered ... Inc. (OTC: GWPC) is a diversified company.  WholeHEALTH ... convenience of advanced technology and proven expertise of ... business of health and wellness.  WholeHEALTH Products, comprehensive ... doctors, clinics and healthcare centers, and 8 retail ...
(Date:11/18/2014)... , Nov. 18, 2014  Cardica, Inc. (Nasdaq: ... Cardica Board has approved management,s recommendation to shift ... of the MicroCutter XCHANGE® 30 surgical stapler to ... launch.  As a result, Cardica has temporarily suspended ... its latest iteration of the MicroCutter XCHANGE 30 ...
(Date:11/18/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... the receipt of approval from the U.S. Food and ... IDEAL IMPLANT ® Saline-filled Breast Implant ... existing augmentation implants. The FDA approval of the IDEAL ... studies and data including a U.S. clinical trial that ...
Breaking Medicine Technology:WholeHEALTH Product Inc. to File FDA Emergency Use Approval (EUA) for PCR Rapid Ebola Test 2Cardica Announces Shift In Focus 2Cardica Announces Shift In Focus 3Valeant Pharmaceuticals And IDEAL IMPLANT Announce FDA And Health Canada Approval To Market Ideal Implant For Cosmetic Breast Augmentation 2Valeant Pharmaceuticals And IDEAL IMPLANT Announce FDA And Health Canada Approval To Market Ideal Implant For Cosmetic Breast Augmentation 3
... 29, 2011 As small businesses struggle to afford ... concern that forthcoming Essential Health Benefits regulations could include ... to raise prescription drug costs, the Pharmaceutical Care ... (PBMs) administer drug benefits for thousands of small businesses ...
... JOLLA, Calif., Sept. 29, 2011 Synthetic Genomics Vaccines, ... next generation vaccines using genomic sequencing and synthetic genomic ... been appointed as president.  Dr. Farah brings extensive vaccine ... executive management experience in the biotechnology industry to SGVI. ...
Cached Medicine Technology:Some Essential Benefits Rules Could Worry Small Businesses 2Synthetic Genomics Vaccines, Inc. Hires Vaccine Executive Sammy J. Farah as President 2
Lyphochek Urine Bone Markers Control is a bilevel human urine based control designed to monitor tests for urinary markers of osteoporosis management and bone resorption....
Lyphochek Maternal Serum Control is a trilevel product with analytes at clinically significant levels to monitor maternal serum analysis....
... Immunoassay Plus Control is a ... in today's busy immunoassay laboratory. ... this human serum based control ... separate control products for immunoassay ...
... The Vidiera NsD Nucleic Sample Detection ... acids, post amplification. The new platform ... by capillary electrophoresis (CE), with software features ... and flexibility. Vidiera NsD has the ...
Medicine Products: